Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors

This publication has 40 references indexed in Scilit:

• Bone markers in the management of metastatic bone disease
  Cancer Treatment Reviews, 2001
• THE USE OF BISPHOSPHONATE FOR THE PALLIATIVE TREATMENT OF PAINFUL BONE METASTASIS DUE TO HORMONE REFRACTORY PROSTATE CANCER
  Journal of Urology, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Collagen crosslinked N‐telopeptides as markers for evaluating particulate osteolysis: A preliminary study
  Journal of Orthopaedic Research, 2000
• Global cancer statistics
  CA: A Cancer Journal for Clinicians, 1999
• Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy
  Drug Safety, 1999
• Distribution of distant metastases from newly diagnosed non-small cell lung cancer
  The Annals of Thoracic Surgery, 1996
• Bone metabolic markers in bone metastases
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1995
• The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study
  European Journal Of Cancer, 1994
• Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer
  Journal of Surgical Oncology, 1983